Genome-wide allelic methylation analysis reveals disease-specific susceptibility to multiple methylation defects in imprinting syndromes. 2013

Franck Court, and Alex Martin-Trujillo, and Valeria Romanelli, and Intza Garin, and Isabel Iglesias-Platas, and Ira Salafsky, and Miriam Guitart, and Guiomar Perez de Nanclares, and Pablo Lapunzina, and David Monk
Imprinting and Cancer Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.

Genomic imprinting is the parent-of-origin-specific allelic transcriptional silencing observed in mammals, which is governed by DNA methylation established in the gametes and maintained throughout the development. The frequency and extent of epimutations associated with the nine reported imprinting syndromes varies because it is evident that aberrant preimplantation maintenance of imprinted differentially methylated regions (DMRs) may affect multiple loci. Using a custom Illumina GoldenGate array targeting 27 imprinted DMRs, we profiled allelic methylation in 65 imprinting defect patients. We identify multilocus hypomethylation in numerous Beckwith-Wiedemann syndrome, transient neonatal diabetes mellitus (TNDM), and pseudohypoparathyroidism 1B patients, and an individual with Silver-Russell syndrome. Our data reveal a broad range of epimutations exist in certain imprinting syndromes, with the exception of Prader-Willi syndrome and Angelman syndrome patients that are associated with solitary SNRPN-DMR defects. A mutation analysis identified a 1 bp deletion in the ZFP57 gene in a TNDM patient with methylation defects at multiple maternal DMRs. In addition, we observe missense variants in ZFP57, NLRP2, and NLRP7 that are not consistent with maternal effect and aberrant establishment or methylation maintenance, and are likely benign. This work illustrates that further extensive molecular characterization of these rare patients is required to fully understand the mechanism underlying the etiology of imprint establishment and maintenance.

UI MeSH Term Description Entries
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011218 Prader-Willi Syndrome An autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 (15q11-q13) or by inheritance of both of the pair of chromosomes 15 from the mother (UNIPARENTAL DISOMY) which are imprinted (GENETIC IMPRINTING) and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. (Menkes, Textbook of Child Neurology, 5th ed, p229) Labhart-Willi Syndrome,Royer Syndrome,Labhart-Willi-Prader-Fanconi Syndrome,Prader Labhart Willi Syndrome,Prader-Labhart-Willi Syndrome,Royer's Syndrome,Willi-Prader Syndrome,Labhart Willi Prader Fanconi Syndrome,Labhart Willi Syndrome,Prader Willi Syndrome,Royers Syndrome,Syndrome, Labhart-Willi,Syndrome, Labhart-Willi-Prader-Fanconi,Syndrome, Prader-Labhart-Willi,Syndrome, Prader-Willi,Syndrome, Royer,Syndrome, Royer's,Syndrome, Willi-Prader,Willi Prader Syndrome
D011546 Pseudohypoaldosteronism A heterogeneous group of disorders characterized by renal electrolyte transport dysfunctions. Congenital forms are rare autosomal disorders characterized by neonatal hypertension, HYPERKALEMIA, increased RENIN activity and ALDOSTERONE concentration. The Type I features HYPERKALEMIA with sodium wasting; Type II, HYPERKALEMIA without sodium wasting. Pseudohypoaldosteronism can be the result of a defective renal electrolyte transport protein or acquired after KIDNEY TRANSPLANTATION. Gordon Hyperkalemia-Hypertension Syndrome,Hyperpotassemia and Hypertension, Familial,Hypertensive Hyperkalemia, Familial,Pseudohypoaldosteronism Type 1,Pseudohypoaldosteronism Type 1, Autosomal Recessive,Pseudohypoaldosteronism, Type I,Pseudohypoaldosteronism, Type I, Autosomal Dominant,Pseudohypoaldosteronism, Type I, Autosomal Recessive,Pseudohypoaldosteronism, Type II,Familial Hyperpotassemia and Hypertension,Familial Hypertensive Hyperkalemia,Pseudohypoaldosteronism Type 1, Autosomal Dominant,Pseudohypoaldosteronism Type 2,Pseudohypoaldosteronism Type I,Pseudohypoaldosteronism Type II,Familial Hypertensive Hyperkalemias,Gordon Hyperkalemia Hypertension Syndrome,Hyperkalemia, Familial Hypertensive,Hyperkalemia-Hypertension Syndrome, Gordon,Hyperkalemias, Familial Hypertensive,Hypertensive Hyperkalemias, Familial,Pseudohypoaldosteronism Type 1s,Pseudohypoaldosteronism Type 2s,Pseudohypoaldosteronism Type IIs,Pseudohypoaldosteronism Type Is,Pseudohypoaldosteronisms,Pseudohypoaldosteronisms, Type I,Pseudohypoaldosteronisms, Type II,Syndrome, Gordon Hyperkalemia-Hypertension,Type 1, Pseudohypoaldosteronism,Type I Pseudohypoaldosteronism,Type I, Pseudohypoaldosteronism,Type II Pseudohypoaldosteronism,Type II Pseudohypoaldosteronisms,Type II, Pseudohypoaldosteronism,Type IIs, Pseudohypoaldosteronism,Type Is, Pseudohypoaldosteronism
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D001506 Beckwith-Wiedemann Syndrome A syndrome of multiple defects characterized primarily by umbilical hernia (HERNIA, UMBILICAL); MACROGLOSSIA; and GIGANTISM; and secondarily by visceromegaly; HYPOGLYCEMIA; and ear abnormalities. Wiedemann Syndrome,Wiedemann-Beckwith Syndrome,Wiedemann-Beckwith Syndrome (WBS),EMG Syndrome,Exomphalos-Macroglossia-Gigantism Syndrome,Beckwith Wiedemann Syndrome,EMG Syndromes,Exomphalos Macroglossia Gigantism Syndrome,Exomphalos-Macroglossia-Gigantism Syndromes,Syndrome, Beckwith-Wiedemann,Syndrome, EMG,Syndrome, Exomphalos-Macroglossia-Gigantism,Syndrome, Wiedemann,Syndrome, Wiedemann-Beckwith,Syndrome, Wiedemann-Beckwith (WBS),Wiedemann Beckwith Syndrome,Wiedemann Beckwith Syndrome (WBS),Wiedemann Syndromes,Wiedemann-Beckwith Syndromes (WBS)
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

Franck Court, and Alex Martin-Trujillo, and Valeria Romanelli, and Intza Garin, and Isabel Iglesias-Platas, and Ira Salafsky, and Miriam Guitart, and Guiomar Perez de Nanclares, and Pablo Lapunzina, and David Monk
January 2016, Clinical epigenetics,
Franck Court, and Alex Martin-Trujillo, and Valeria Romanelli, and Intza Garin, and Isabel Iglesias-Platas, and Ira Salafsky, and Miriam Guitart, and Guiomar Perez de Nanclares, and Pablo Lapunzina, and David Monk
May 2001, Cancer research,
Franck Court, and Alex Martin-Trujillo, and Valeria Romanelli, and Intza Garin, and Isabel Iglesias-Platas, and Ira Salafsky, and Miriam Guitart, and Guiomar Perez de Nanclares, and Pablo Lapunzina, and David Monk
October 2023, Gene,
Franck Court, and Alex Martin-Trujillo, and Valeria Romanelli, and Intza Garin, and Isabel Iglesias-Platas, and Ira Salafsky, and Miriam Guitart, and Guiomar Perez de Nanclares, and Pablo Lapunzina, and David Monk
September 2021, The Plant journal : for cell and molecular biology,
Franck Court, and Alex Martin-Trujillo, and Valeria Romanelli, and Intza Garin, and Isabel Iglesias-Platas, and Ira Salafsky, and Miriam Guitart, and Guiomar Perez de Nanclares, and Pablo Lapunzina, and David Monk
November 2008, American journal of human genetics,
Franck Court, and Alex Martin-Trujillo, and Valeria Romanelli, and Intza Garin, and Isabel Iglesias-Platas, and Ira Salafsky, and Miriam Guitart, and Guiomar Perez de Nanclares, and Pablo Lapunzina, and David Monk
June 2018, Scientific reports,
Franck Court, and Alex Martin-Trujillo, and Valeria Romanelli, and Intza Garin, and Isabel Iglesias-Platas, and Ira Salafsky, and Miriam Guitart, and Guiomar Perez de Nanclares, and Pablo Lapunzina, and David Monk
June 2008, PLoS genetics,
Franck Court, and Alex Martin-Trujillo, and Valeria Romanelli, and Intza Garin, and Isabel Iglesias-Platas, and Ira Salafsky, and Miriam Guitart, and Guiomar Perez de Nanclares, and Pablo Lapunzina, and David Monk
October 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Franck Court, and Alex Martin-Trujillo, and Valeria Romanelli, and Intza Garin, and Isabel Iglesias-Platas, and Ira Salafsky, and Miriam Guitart, and Guiomar Perez de Nanclares, and Pablo Lapunzina, and David Monk
January 2012, Fertility and sterility,
Franck Court, and Alex Martin-Trujillo, and Valeria Romanelli, and Intza Garin, and Isabel Iglesias-Platas, and Ira Salafsky, and Miriam Guitart, and Guiomar Perez de Nanclares, and Pablo Lapunzina, and David Monk
April 2015, Genomics,
Copied contents to your clipboard!